• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·ELMD
Held by 1 Guru
Share

Electromed, Inc. Stocks

$ 37.14Last Updated 17.06.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

$ 310.92M

$ 37.14
Key Takeaways

Risk factor

Meaningful price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

In Guru Portfolios

Data is available to registered users only
Data is available to registered users only

Portfolio Weight (%)

Data is available to registered users only

Change

Data is available to registered users only

Fund

Data is available to registered users only
Data is available to registered users only
Data is available to registered users only

Portfolio Weight (%)

Data is available to registered users only

Change

Data is available to registered users only

Fund

Data is available to registered users only
Data is available to registered users only
Data is available to registered users only

Portfolio Weight (%)

Data is available to registered users only

Change

Data is available to registered users only

Fund

Data is available to registered users only
Manager
Fund
Portfolio Weight (%)
Change
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Sign up, to see portfolios that hold this stock
Sign up, to see portfolios that hold this stock

Latest news

29.12.2025 20:00

Online games, metals, energy: Freedom Broker spotlights eight smid stocks for 2026

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Electromed, Inc. is engaged in the creation, production, and sale of respiratory therapy devices. Their focus is on delivering airway clearance through High Frequency Chest Wall Oscillation (HFCWO) technology, aiding pulmonary care for individuals of all ages across the United States and globally. The company's key offering is the SmartVest airway clearance system. This includes the SmartVest SQL System, an innovative solution comprising an inflatable therapy garment, a customizable air pulse generator, and a distinctive single-hose design for air delivery. They also provide SmartVest Connect, a wireless platform enabling personalized HFCWO therapy management for patients with diminished lung function. For acute care settings, Electromed supplies single-use SmartVest and SmartVest Wrap products to healthcare providers. Electromed's primary market is home healthcare, catering to patients diagnosed with conditions such as bronchiectasis, cystic fibrosis, and neuromuscular disease. The company distributes its products via medical professionals, healthcare facilities, and directly to consumers. Established in 1992, Electromed, Inc. is based in New Prague, Minnesota.

Company Valuation

Overvalued
2/7

Considering past and projected metrics, the stock is 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA, overpriced

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of ELMD is 38 and suggests 3.5% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation s

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

20.06.2026 00:00

Down 80%: Six Stocks Bought by an Investor from "The Short Game"

19.06.2026 23:10

Goldman Sachs Expects a Data Center Boom in Asia. What Do Investors Need to Know?

19.06.2026 22:27

AbbVie is preparing to acquire a dermatitis drug developer for $11 billion — FT

19.06.2026 20:39

Iran may require ships to pay "insurance fees" for passing through the Strait of Hormuz

19.06.2026 19:10

Can 'kiadults' power the next phase of Build-A-Bear’s growth?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026